Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Systemic lupus erythematosus	15/133	0.0026884119978347687	0.8280308953331088	0	0	2.2556390977443606	13.350687056531578	HIST1H2AL;HIST1H2BL;HIST2H4A;HIST1H4A;HLA-DMA;HIST1H3A;HLA-DMB;HIST1H3B;HIST1H4C;HIST1H4D;HIST1H2AC;HIST1H4E;HIST1H2AB;HIST1H2BC;HLA-DQB1
Alcoholism	15/180	0.03669787618232015	1.0	0	0	1.6666666666666665	5.508393992146127	HIST1H2AL;SHC1;BDNF;HIST1H2BL;HIST2H4A;HIST1H4A;HIST1H3A;TH;HIST1H3B;HIST1H4C;HIST1H4D;HIST1H2AC;HIST1H4E;HIST1H2AB;HIST1H2BC
Acute myeloid leukemia	7/66	0.0461316060876481	1.0	0	0	2.121212121212121	6.525393563105938	STAT5A;CCNA1;TCF7L1;SPI1;CHUK;EIF4EBP1;DUSP6
Selenocompound metabolism	3/17	0.05017800549335433	1.0	0	0	3.5294117647058822	10.56062995015536	CTH;MARS;SCLY
Parkinson disease	12/142	0.05262184308995271	1.0	0	0	1.6901408450704225	4.976829257862233	NDUFA13;NDUFA6;NDUFA11;TH;NDUFS7;NDUFB6;UBE2L6;UQCR11;PARK7;SDHB;SEPT5;COX6B1
Breast cancer	12/147	0.06498348347211058	1.0	0	0	1.6326530612244896	4.4630565580482475	NCOA1;NOTCH3;TCF7L1;GADD45B;SHC1;NOTCH4;FGF19;FLT4;DVL2;E2F3;WNT9A;BRCA2
Lysine degradation	6/59	0.073523209939382	1.0	0	0	2.0338983050847457	5.308788083641293	GCDH;KMT2A;EHHADH;NSD2;SETD1A;KMT5B
Synthesis and degradation of ketone bodies	2/10	0.08609691405925976	1.0	0	0	4.0	9.809126838186547	HMGCL;OXCT1
Lysosome	10/123	0.0885699310505985	1.0	0	0	1.6260162601626016	3.9414030205438846	ABCA2;LAMP1;HYAL1;FUCA1;GBA;AP3D1;CLTA;AP1S3;ATP6V0D1;AP1M2
Synaptic vesicle cycle	7/78	0.09474562652597404	1.0	0	0	1.7948717948717947	4.2297223484243345	NAPA;SLC6A9;SLC6A13;CLTA;SLC6A11;ATP6V0D1;STX1A
Glycerophospholipid metabolism	8/97	0.11221289529851242	1.0	0	0	1.6494845360824741	3.608012142083881	PTDSS2;ACHE;PHOSPHO1;PLPP5;PLA2G2E;CHKA;PLA2G4B;LPIN1
Retinol metabolism	6/67	0.11758211344423333	1.0	0	0	1.7910447761194028	3.8339433163846697	UGT2B11;ADH1C;UGT1A4;DHRS4L2;BCO1;CYP3A5
Oxidative phosphorylation	10/133	0.12962027533045753	1.0	0	0	1.5037593984962405	3.0724000930063378	NDUFA13;NDUFA6;NDUFA11;NDUFS7;NDUFB6;UQCR11;ATP6V0D1;SDHB;COX6B1;LHPP
Ribosome biogenesis in eukaryotes	8/101	0.1327237667281199	1.0	0	0	1.584158415841584	3.1991845583986054	NXF1;RNA5S12;REXO1;CSNK2A1;RIOK1;RPP25L;RMRP;NOL6
Prolactin signaling pathway	6/70	0.13686946768775143	1.0	0	0	1.7142857142857142	3.4092473107677503	STAT5A;GALT;TH;SHC1;ELF5;MAPK12
Transcriptional misregulation in cancer	13/186	0.14053179803192992	1.0	0	0	1.3978494623655913	2.7430300471977467	DDX5;SPI1;KMT2A;GADD45B;SIX1;DUSP6;ELK4;CCNA1;HIST1H3A;NSD2;TCF3;UTY;HIST1H3B
Ascorbate and aldarate metabolism	3/27	0.15038161447469178	1.0	0	0	2.222222222222222	4.210175820273459	UGT2B11;RGN;UGT1A4
Butanoate metabolism	3/28	0.16255339603696525	1.0	0	0	2.142857142857143	3.893033014692501	HMGCL;OXCT1;EHHADH
Leishmaniasis	6/74	0.1647057705275506	1.0	0	0	1.6216216216216217	2.924748009429989	HLA-DMA;CR1;HLA-DMB;FCGR2C;MAPK12;HLA-DQB1
Th1 and Th2 cell differentiation	7/92	0.1766966657885233	1.0	0	0	1.5217391304347827	2.6376620400404125	STAT5A;NOTCH3;HLA-DMA;HLA-DMB;CHUK;MAPK12;HLA-DQB1
Chronic myeloid leukemia	6/76	0.17945756311992533	1.0	0	0	1.5789473684210524	2.712341867627267	STAT5A;CHUK;GADD45B;SHC1;E2F3;CRKL
ABC transporters	4/45	0.18643368284604128	1.0	0	0	1.7777777777777777	2.98609722860718	ABCA2;ABCG8;ABCC6;ABCA7
Asthma	3/31	0.20065196718317338	1.0	0	0	1.9354838709677418	3.1087420224475646	HLA-DMA;HLA-DMB;HLA-DQB1
beta-Alanine metabolism	3/31	0.20065196718317338	1.0	0	0	1.9354838709677418	3.1087420224475646	AOC3;EHHADH;CNDP1
Basal cell carcinoma	5/63	0.20636211070548938	1.0	0	0	1.5873015873015872	2.504956879983314	TCF7L1;GADD45B;SUFU;DVL2;WNT9A
Non-alcoholic fatty liver disease (NAFLD)	10/149	0.21263497715518503	1.0	0	0	1.3422818791946307	2.0780916854371307	SREBF1;NDUFA13;PRKAA1;NDUFA6;NDUFA11;NDUFS7;NDUFB6;UQCR11;SDHB;COX6B1
Other glycan degradation	2/18	0.22645148897005046	1.0	0	0	2.222222222222222	3.3004989638462865	FUCA1;GBA
N-Glycan biosynthesis	4/50	0.2394412597417243	1.0	0	0	1.5999999999999999	2.287115446802478	B4GALT3;DPM3;GANAB;ALG14
Huntington disease	12/193	0.2595912518027711	1.0	0	0	1.2435233160621761	1.6770739815254025	NDUFA13;NDUFA6;NDUFA11;NDUFS7;NDUFB6;BDNF;POLR2E;CLTA;UQCR11;SDHB;BBC3;COX6B1
DNA replication	3/36	0.2678594070249647	1.0	0	0	1.6666666666666665	2.1954883946257717	RNASEH2A;PRIM1;MCM3
Tyrosine metabolism	3/36	0.2678594070249647	1.0	0	0	1.6666666666666665	2.1954883946257717	AOC3;ADH1C;TH
Autoimmune thyroid disease	4/53	0.272750159994601	1.0	0	0	1.5094339622641508	1.9610551964847422	HLA-DMA;HLA-DMB;TG;HLA-DQB1
Glycosaminoglycan biosynthesis	4/53	0.272750159994601	1.0	0	0	1.5094339622641508	1.9610551964847422	B4GALT3;CHST11;B3GAT3;HS3ST1
Thyroid cancer	3/37	0.2816374857336128	1.0	0	0	1.6216216216216217	2.054812778279635	TCF7L1;GADD45B;CDH1
Pathogenic Escherichia coli infection	4/55	0.2953729340320737	1.0	0	0	1.4545454545454544	1.773842236930121	TUBA1A;CDH1;NCK2;TUBB4A
Allograft rejection	3/38	0.29547545275268733	1.0	0	0	1.5789473684210524	1.9250044986274375	HLA-DMA;HLA-DMB;HLA-DQB1
mRNA surveillance pathway	6/91	0.303383440861158	1.0	0	0	1.3186813186813187	1.5728674181927342	NXF1;DAZAP1;PABPN1;PPP2R1A;MSI1;SRRM1
Viral carcinogenesis	12/201	0.3054856995308486	1.0	0	0	1.1940298507462686	1.4159430585223085	STAT5A;DDB1;HIST2H4A;CCNA1;HIST1H4A;HIST1H2BL;CCR8;ATP6V0D1;HIST1H4C;HIST1H4D;HIST1H4E;HIST1H2BC
Bacterial invasion of epithelial cells	5/74	0.31110059336369467	1.0	0	0	1.3513513513513513	1.577890496988918	CDH1;SHC1;CLTA;BCAR1;CRKL
Glycine, serine and threonine metabolism	3/40	0.3232493972692518	1.0	0	0	1.4999999999999998	1.693996688892286	AOC3;SRR;CTH
Bladder cancer	3/41	0.3371468638537048	1.0	0	0	1.4634146341463412	1.5910780182096236	CDH1;DAPK3;E2F3
Graft-versus-host disease	3/41	0.3371468638537048	1.0	0	0	1.4634146341463412	1.5910780182096236	HLA-DMA;HLA-DMB;HLA-DQB1
Phagosome	9/152	0.35009569492044973	1.0	0	0	1.1842105263157894	1.2428866750394152	HLA-DMA;TUBA1A;HLA-DMB;LAMP1;CD209;ATP6V0D1;TUBB4A;FCGR2C;HLA-DQB1
Alzheimer disease	10/171	0.3516875864008027	1.0	0	0	1.1695906432748537	1.2222362995482308	NDUFA13;NDUFA6;NDUFA11;NDUFS7;NDUFB6;ATP2A2;UQCR11;SDHB;GAPDH;COX6B1
alpha-Linolenic acid metabolism	2/25	0.3576694978288805	1.0	0	0	1.5999999999999999	1.645033455050064	PLA2G2E;PLA2G4B
Type I diabetes mellitus	3/43	0.36487351009848823	1.0	0	0	1.3953488372093021	1.4067970229812217	HLA-DMA;HLA-DMB;HLA-DQB1
Fatty acid degradation	3/44	0.3786697727707907	1.0	0	0	1.3636363636363635	1.3242146804495836	GCDH;ADH1C;EHHADH
Inflammatory mediator regulation of TRP channels	6/100	0.38397671632870417	1.0	0	0	1.2	1.1486080353521109	PLA2G4B;HTR2C;TRPM8;HTR2A;ASIC3;MAPK12
Measles	8/138	0.38588815366024015	1.0	0	0	1.1594202898550725	1.1040089378109808	STAT5A;CSNK2A1;CHUK;CD209;CD46;SLAMF1;TP73;BBC3
AMPK signaling pathway	7/120	0.39363540297261096	1.0	0	0	1.1666666666666665	1.0877185331509394	SREBF1;CCNA1;PRKAA1;EEF2K;PPP2R1A;EIF4EBP1;EEF2
Biosynthesis of unsaturated fatty acids	2/27	0.39397603610044213	1.0	0	0	1.4814814814814814	1.3799484349837585	ACOT7;ELOVL5
Fatty acid elongation	2/27	0.39397603610044213	1.0	0	0	1.4814814814814814	1.3799484349837585	ACOT7;ELOVL5
Tuberculosis	10/179	0.4057408879304794	1.0	0	0	1.1173184357541899	1.007866514177665	HLA-DMA;CR1;HLA-DMB;LAMP1;CD209;NOD2;ATP6V0D1;FCGR2C;MAPK12;HLA-DQB1
Hippo signaling pathway	9/160	0.4073910770526227	1.0	0	0	1.125	1.0102293873083648	TCF7L1;LATS2;PPP2R1A;CDH1;DVL2;WNT9A;FRMD1;TP73;BBC3
Inflammatory bowel disease (IBD)	4/65	0.41006047139933866	1.0	0	0	1.2307692307692308	1.0971700171589474	HLA-DMA;HLA-DMB;NOD2;HLA-DQB1
Shigellosis	4/65	0.41006047139933866	1.0	0	0	1.2307692307692308	1.0971700171589474	CHUK;NOD2;MAPK12;CRKL
Human T-cell leukemia virus 1 infection	12/219	0.4145128742255005	1.0	0	0	1.095890410958904	0.9650972550550574	ELK4;STAT5A;CCNA1;HLA-DMA;SPI1;HLA-DMB;CHUK;CRTC1;TSPO;E2F3;TCF3;HLA-DQB1
ErbB signaling pathway	5/85	0.42118396120911705	1.0	0	0	1.176470588235294	1.0172771508801166	STAT5A;SHC1;NCK2;EIF4EBP1;CRKL
Aminoacyl-tRNA biosynthesis	4/66	0.421430857889875	1.0	0	0	1.2121212121212122	1.0473933978386722	VARS;MARS;TARS;FARS2
Linoleic acid metabolism	2/29	0.42931633359945176	1.0	0	0	1.379310344827586	1.1662913895494167	PLA2G2E;PLA2G4B
Intestinal immune network for IgA production	3/48	0.43306631871249	1.0	0	0	1.25	1.0460805021359667	HLA-DMA;HLA-DMB;HLA-DQB1
Notch signaling pathway	3/48	0.43306631871249	1.0	0	0	1.25	1.0460805021359667	NOTCH3;NOTCH4;DVL2
Valine, leucine and isoleucine degradation	3/48	0.43306631871249	1.0	0	0	1.25	1.0460805021359667	HMGCL;OXCT1;EHHADH
Staphylococcus aureus infection	4/68	0.44400267624141365	1.0	0	0	1.176470588235294	0.9552055164674429	HLA-DMA;HLA-DMB;FCGR2C;HLA-DQB1
Arginine and proline metabolism	3/49	0.44640402063272916	1.0	0	0	1.2244897959183672	0.987588809585937	ALDH4A1;CNDP1;AGMAT
Citrate cycle (TCA cycle)	2/30	0.44657352514826887	1.0	0	0	1.3333333333333333	1.0748682963163632	OGDH;SDHB
Pentose phosphate pathway	2/30	0.44657352514826887	1.0	0	0	1.3333333333333333	1.0748682963163632	RGN;TKT
Th17 cell differentiation	6/107	0.44689369780524896	1.0	0	0	1.1214953271028036	0.903291056261686	STAT5A;HLA-DMA;HLA-DMB;CHUK;MAPK12;HLA-DQB1
Drug metabolism	6/108	0.45579415117862115	1.0	0	0	1.111111111111111	0.8730155491595808	RRM1;UGT2B11;ADH1C;UGT1A4;TK2;CYP3A5
Autophagy	7/128	0.45946687100202477	1.0	0	0	1.09375	0.8505967287493645	PRKAA1;LAMP1;ATG101;DAPK3;ATG2A;MLST8;ATG4D
Cholesterol metabolism	3/50	0.4596144044474325	1.0	0	0	1.2	0.9328408706750739	ABCG8;VAPA;TSPO
Circadian rhythm	2/31	0.46353362563600886	1.0	0	0	1.2903225806451613	0.9920985153401862	PER1;PRKAA1
Mucin type O-glycan biosynthesis	2/31	0.46353362563600886	1.0	0	0	1.2903225806451613	0.9920985153401862	GALNT16;GALNT10
Gastric cancer	8/149	0.46993598574671025	1.0	0	0	1.0738255033557047	0.8109087721804916	TCF7L1;GADD45B;CDH1;SHC1;FGF19;DVL2;E2F3;WNT9A
TNF signaling pathway	6/110	0.4734883847029237	1.0	0	0	1.0909090909090908	0.8155940698683591	EDN1;MLKL;CHUK;NOD2;JUNB;MAPK12
Thermogenesis	12/231	0.48810556698325097	1.0	0	0	1.0389610389610389	0.7451673462220139	NDUFA13;PRKAA1;NDUFA6;NDUFA11;NDUFS7;NDUFB6;MLST8;SIRT6;UQCR11;SDHB;MAPK12;COX6B1
Adherens junction	4/72	0.48826565745953704	1.0	0	0	1.111111111111111	0.7965507124555724	TCF7L1;CSNK2A1;CDH1;NECTIN4
Melanoma	4/72	0.48826565745953704	1.0	0	0	1.111111111111111	0.7965507124555724	GADD45B;CDH1;FGF19;E2F3
Toxoplasmosis	6/113	0.4997075653239782	1.0	0	0	1.0619469026548671	0.7367067833785346	HLA-DMA;HLA-DMB;CHUK;LAMB2;MAPK12;HLA-DQB1
Metabolism of xenobiotics by cytochrome P450	4/74	0.5098528753630284	1.0	0	0	1.0810810810810811	0.7282519724998587	UGT2B11;ADH1C;UGT1A4;CYP3A5
Fanconi anemia pathway	3/54	0.5109953414593842	1.0	0	0	1.111111111111111	0.7459942281531415	TOP3B;BRCA2;FANCE
Pentose and glucuronate interconversions	2/34	0.5125071338352726	1.0	0	0	1.176470588235294	0.7864007628092599	UGT2B11;UGT1A4
SNARE interactions in vesicular transport	2/34	0.5125071338352726	1.0	0	0	1.176470588235294	0.7864007628092599	VAMP1;STX1A
Pancreatic cancer	4/75	0.520490485053102	1.0	0	0	1.0666666666666667	0.6965159162578138	CHUK;GADD45B;E2F3;BRCA2
Hematopoietic cell lineage	5/97	0.5371052771771576	1.0	0	0	1.0309278350515463	0.6407846977351693	HLA-DMA;CR1;HLA-DMB;EPO;HLA-DQB1
Pyrimidine metabolism	3/57	0.5477812798713707	1.0	0	0	1.0526315789473684	0.6335570484502631	NT5C3B;RRM1;TK2
Neurotrophin signaling pathway	6/119	0.5506572107989453	1.0	0	0	1.0084033613445378	0.6016565903086142	NTF4;SHC1;BDNF;MAPK12;CRKL;TP73
Epstein-Barr virus infection	10/201	0.5523179780186385	1.0	0	0	0.9950248756218906	0.5906779616132228	CCNA1;HLA-DMA;HLA-DMB;PSMD4;GADD45B;CHUK;ISG15;E2F3;MAPK12;HLA-DQB1
Endometrial cancer	3/58	0.559676962497205	1.0	0	0	1.0344827586206895	0.6004091528069233	TCF7L1;GADD45B;CDH1
Complement and coagulation cascades	4/79	0.561890006637219	1.0	0	0	1.0126582278481011	0.5837459908567373	CR1;CD46;KLKB1;F2RL3
Viral myocarditis	3/59	0.5713815260202666	1.0	0	0	1.0169491525423728	0.5691845296161483	HLA-DMA;HLA-DMB;HLA-DQB1
Phenylalanine metabolism	1/17	0.5820286217003197	1.0	0	0	1.176470588235294	0.6367478285654856	AOC3
Steroid hormone biosynthesis	3/60	0.5828910435264506	1.0	0	0	1.0	0.5397549994176116	UGT2B11;UGT1A4;CYP3A5
RNA transport	8/165	0.5863836234120163	1.0	0	0	0.9696969696969696	0.5176058726133539	NUP214;NXF1;NUP210L;EIF4EBP1;AAAS;RPP25L;EIF3A;SRRM1
Cell cycle	6/124	0.5912375561010063	1.0	0	0	0.9677419354838709	0.5085845672526835	CCNA1;TFDP1;GADD45B;MCM3;E2F3;CDC25B
Chemical carcinogenesis	4/82	0.591620653904691	1.0	0	0	0.975609756097561	0.5120874505494942	UGT2B11;ADH1C;UGT1A4;CYP3A5
Cell adhesion molecules (CAMs)	7/145	0.5920854218584392	1.0	0	0	0.9655172413793103	0.5060317966611959	CLDN4;HLA-DMA;HLA-DMB;CDH1;CLDN9;ICAM3;HLA-DQB1
Ferroptosis	2/40	0.60119891797304	1.0	0	0	1.0	0.5088294208836465	FTMT;GPX4
Osteoclast differentiation	6/127	0.6146383855730021	1.0	0	0	0.9448818897637795	0.45989402366767695	SPI1;CHUK;JUNB;FCGR2C;MAPK12;LILRA5
Fat digestion and absorption	2/41	0.6147400385913487	1.0	0	0	0.975609756097561	0.47468858733322344	ABCG8;PLA2G2E
Homologous recombination	2/41	0.6147400385913487	1.0	0	0	0.975609756097561	0.47468858733322344	TOP3B;BRCA2
Tight junction	8/170	0.6202201527232523	1.0	0	0	0.9411764705882353	0.4495819095842526	MYH1;CLDN4;PRKAA1;TUBA1A;PPP2R1A;CLDN9;TJP3;RAB8B
Glycosaminoglycan degradation	1/19	0.6228154838888618	1.0	0	0	1.0526315789473684	0.4984262922061619	HYAL1
Porphyrin and chlorophyll metabolism	2/42	0.6279256694973029	1.0	0	0	0.9523809523809523	0.4431747430401906	UGT2B11;UGT1A4
Tryptophan metabolism	2/42	0.6279256694973029	1.0	0	0	0.9523809523809523	0.4431747430401906	GCDH;EHHADH
Colorectal cancer	4/86	0.6293463661035574	1.0	0	0	0.9302325581395349	0.4307660579611482	TCF7L1;MSH2;GADD45B;BBC3
mTOR signaling pathway	7/152	0.6417021441357289	1.0	0	0	0.9210526315789472	0.4086075302976567	PRKAA1;CHUK;EIF4EBP1;DVL2;MLST8;WNT9A;LPIN1
Gap junction	4/88	0.6473496582204271	1.0	0	0	0.9090909090909091	0.39533518222257213	TUBA1A;HTR2C;HTR2A;TUBB4A
Non-small cell lung cancer	3/66	0.6476960862533626	1.0	0	0	0.9090909090909091	0.3948488139467768	STAT5A;GADD45B;E2F3
Pathways in cancer	25/530	0.6478598176654922	1.0	0	0	0.9433962264150944	0.40951031773194957	NOTCH3;SPI1;EPO;NOTCH4;FLT4;BRCA2;BBC3;CRKL;CDH1;SUFU;DVL2;E2F3;STAT5A;NCOA1;EDN1;TCF7L1;CHUK;GADD45B;LAMB2;DAPK3;WNT9A;CCNA1;MSH2;FGF19;F2RL3
Glycosphingolipid biosynthesis	2/45	0.665369764985953	1.0	0	0	0.8888888888888888	0.3621443158089169	B4GALT3;B4GALNT1
Epithelial cell signaling in Helicobacter pylori infection	3/68	0.6676380497864279	1.0	0	0	0.8823529411764706	0.3564786122927678	CHUK;ATP6V0D1;MAPK12
Rheumatoid arthritis	4/91	0.6732482464251353	1.0	0	0	0.8791208791208791	0.34781639730574376	HLA-DMA;HLA-DMB;ATP6V0D1;HLA-DQB1
Other types of O-glycan biosynthesis	1/22	0.6766623505215513	1.0	0	0	0.9090909090909091	0.3550753401584873	B4GALT3
Terpenoid backbone biosynthesis	1/22	0.6766623505215513	1.0	0	0	0.9090909090909091	0.3550753401584873	DHDDS
Endocytosis	11/244	0.6804800816371734	1.0	0	0	0.9016393442622951	0.3470921313586251	EHD1;ARFGEF1;RAB31;MVB12A;CLTA;SNX32;SNF8;FOLR1;EPN1;SH3GL1;ARFGAP2
RIG-I-like receptor signaling pathway	3/70	0.6867423738774998	1.0	0	0	0.8571428571428571	0.32211090747805676	CHUK;ISG15;MAPK12
Insulin signaling pathway	6/137	0.6868931771447399	1.0	0	0	0.8759124087591241	0.3289721085839843	SREBF1;PRKAA1;SHC1;EIF4EBP1;RHOQ;CRKL
Cysteine and methionine metabolism	2/47	0.6886033156551076	1.0	0	0	0.8510638297872339	0.3175233302317852	MTAP;CTH
Ether lipid metabolism	2/47	0.6886033156551076	1.0	0	0	0.8510638297872339	0.3175233302317852	PLA2G2E;PLA2G4B
Nucleotide excision repair	2/47	0.6886033156551076	1.0	0	0	0.8510638297872339	0.3175233302317852	DDB1;RAD23A
Small cell lung cancer	4/93	0.6897669196744971	1.0	0	0	0.8602150537634409	0.3194851922842808	CHUK;GADD45B;LAMB2;E2F3
Histidine metabolism	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	CNDP1
Mannose type O-glycan biosynthesis	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	B4GALT3
Mismatch repair	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	MSH2
Renin-angiotensin system	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	KLK2
Amino sugar and nucleotide sugar metabolism	2/48	0.6997136081858564	1.0	0	0	0.8333333333333333	0.29757013234898655	CYB5R1;GALT
Endocrine and other factor-regulated calcium reabsorption	2/48	0.6997136081858564	1.0	0	0	0.8333333333333333	0.29757013234898655	CLTA;KLK2
Signaling pathways regulating pluripotency of stem cells	6/139	0.7002204199629493	1.0	0	0	0.8633093525179856	0.30764901396557814	DVL2;NANOG;TCF3;WNT9A;POU5F1;MAPK12
p53 signaling pathway	3/72	0.7050123870135998	1.0	0	0	0.8333333333333333	0.2912832550768055	GADD45B;BBC3;TP73
Vitamin digestion and absorption	1/24	0.7082222339049663	1.0	0	0	0.8333333333333333	0.28749778737100123	TCN2
Cocaine addiction	2/49	0.7104927276749392	1.0	0	0	0.8163265306122448	0.2790176057147895	TH;BDNF
Prostate cancer	4/97	0.7210011321847114	1.0	0	0	0.8247422680412371	0.269785213526288	TCF7L1;CHUK;INSRR;E2F3
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/25	0.7228285803914951	1.0	0	0	0.7999999999999999	0.2596665438632063	PIGU
Glioma	3/75	0.7308710279969972	1.0	0	0	0.7999999999999999	0.2508146136696121	GADD45B;SHC1;E2F3
Folate biosynthesis	1/26	0.7367044256304639	1.0	0	0	0.7692307692307693	0.2350527061077511	TH
HIF-1 signaling pathway	4/100	0.7428559954663433	1.0	0	0	0.7999999999999999	0.23780245442692988	EDN1;EPO;EIF4EBP1;GAPDH
Antigen processing and presentation	3/77	0.7470972136000291	1.0	0	0	0.7792207792207791	0.22718958204818146	HLA-DMA;HLA-DMB;HLA-DQB1
Melanogenesis	4/101	0.7498448770134236	1.0	0	0	0.792079207920792	0.22803083128155077	EDN1;TCF7L1;DVL2;WNT9A
Collecting duct acid secretion	1/27	0.7498862689651448	1.0	0	0	0.7407407407407407	0.2132101669113366	ATP6V0D1
Cardiac muscle contraction	3/78	0.7549122409335416	1.0	0	0	0.7692307692307693	0.2162721335871487	ATP2A2;UQCR11;COX6B1
Retrograde endocannabinoid signaling	6/148	0.7553912967971983	1.0	0	0	0.8108108108108109	0.22744815412465288	NDUFA13;NDUFA6;NDUFA11;NDUFS7;NDUFB6;MAPK12
Influenza A	7/171	0.7571154708373605	1.0	0	0	0.8187134502923976	0.22779842084269228	NXF1;HLA-DMA;HLA-DMB;PABPN1;MAPK12;KPNA1;HLA-DQB1
Phototransduction	1/28	0.7624087879510514	1.0	0	0	0.7142857142857142	0.19376600001083732	SAG
RNA degradation	3/79	0.7625315297227274	1.0	0	0	0.7594936708860759	0.2059074082780564	PAN2;DDX6;EXOSC3
Human papillomavirus infection	14/330	0.7730046957379241	1.0	0	0	0.8484848484848485	0.21845952606533736	HES7;NOTCH3;TCF7L1;CHUK;LAMB2;NOTCH4;ISG15;WNT9A;CCNA1;PPP2R1A;EIF4EBP1;DVL2;ATP6V0D1;HES4
Glutathione metabolism	2/56	0.7771517166186133	1.0	0	0	0.7142857142857142	0.180085491565519	RRM1;GPX4
Oxytocin signaling pathway	6/153	0.7826524992964198	1.0	0	0	0.7843137254901961	0.19220901041264157	MYLK2;PRKAA1;EEF2K;NPR2;PLA2G4B;EEF2
Ribosome	6/153	0.7826524992964198	1.0	0	0	0.7843137254901961	0.19220901041264157	RPS15;RPL41;RNA5S12;RPLP1;RPL36;RPL35
Nicotinate and nicotinamide metabolism	1/30	0.785605993701368	1.0	0	0	0.6666666666666666	0.16086659500936684	NT5C3B
Vascular smooth muscle contraction	5/132	0.7953524382434503	1.0	0	0	0.7575757575757576	0.17346207880243836	MYLK2;EDN1;PLA2G2E;NPR2;PLA2G4B
Galactose metabolism	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	GALT
RNA polymerase	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	POLR2E
VEGF signaling pathway	2/59	0.8013529002820844	1.0	0	0	0.6779661016949152	0.15013820630777816	PLA2G4B;MAPK12
Hypertrophic cardiomyopathy (HCM)	3/85	0.8042799356196909	1.0	0	0	0.7058823529411764	0.15374674713305503	EDN1;PRKAA1;ATP2A2
Propanoate metabolism	1/32	0.806540365201665	1.0	0	0	0.625	0.13437583301390715	EHHADH
MAPK signaling pathway	12/295	0.8068636870379364	1.0	0	0	0.8135593220338982	0.17459026835927283	ELK4;NTF4;GADD45B;CHUK;BDNF;FGF19;FLT4;PLA2G4B;DUSP6;MAPK12;CRKL;CDC25B
Wnt signaling pathway	6/158	0.8075497749747111	1.0	0	0	0.7594936708860759	0.1623422164173327	TCF7L1;CSNK2A1;CHD8;DVL2;CACYBP;WNT9A
Long-term depression	2/60	0.8088860547790443	1.0	0	0	0.6666666666666666	0.14139814589399213	PPP2R1A;PLA2G4B
Glycerolipid metabolism	2/61	0.8161634632362453	1.0	0	0	0.6557377049180327	0.1332069649091696	PLPP5;LPIN1
Leukocyte transendothelial migration	4/112	0.8173248241169633	1.0	0	0	0.7142857142857142	0.14408477257015773	CLDN4;CLDN9;MAPK12;BCAR1
Ras signaling pathway	9/232	0.8253743816905332	1.0	0	0	0.7758620689655172	0.14890205140851023	NTF4;PLA2G2E;CHUK;SHC1;BDNF;FGF19;FLT4;PLA2G4B;EXOC2
Necroptosis	6/162	0.8258200247560288	1.0	0	0	0.7407407407407407	0.14176179030125863	STAT5A;HIST1H2AL;MLKL;PLA2G4B;HIST1H2AC;HIST1H2AB
Arachidonic acid metabolism	2/63	0.8299778549215587	1.0	0	0	0.6349206349206349	0.1183214345173536	PLA2G2E;PLA2G4B
Cytosolic DNA-sensing pathway	2/63	0.8299778549215587	1.0	0	0	0.6349206349206349	0.1183214345173536	CHUK;POLR2E
Hepatitis B	6/163	0.8301653781445008	1.0	0	0	0.7361963190184049	0.13702847651248054	STAT5A;DDB1;CCNA1;CHUK;E2F3;MAPK12
Alanine, aspartate and glutamate metabolism	1/35	0.8341755971925006	1.0	0	0	0.5714285714285714	0.103606486053202	ALDH4A1
Protein digestion and absorption	3/90	0.8341902087803339	1.0	0	0	0.6666666666666666	0.120862556363351	CELA2A;ELN;COL7A1
Thyroid hormone signaling pathway	4/116	0.8378353080759515	1.0	0	0	0.689655172413793	0.1220232603840384	NCOA1;NOTCH3;NOTCH4;ATP2A2
Starch and sucrose metabolism	1/36	0.8424812699182175	1.0	0	0	0.5555555555555555	0.09522436030767889	GYG1
Mitophagy	2/65	0.8428493095437481	1.0	0	0	0.6153846153846154	0.10521051812214251	FIS1;CSNK2A1
IL-17 signaling pathway	3/93	0.8501804853980194	1.0	0	0	0.6451612903225806	0.10471394598415903	CHUK;MUC5B;MAPK12
Aldosterone-regulated sodium reabsorption	1/37	0.8503713249208762	1.0	0	0	0.5405405405405406	0.08761198488762709	NR3C2
Hepatocellular carcinoma	6/168	0.8506043343825483	1.0	0	0	0.7142857142857142	0.11557728607067765	TCF7L1;GADD45B;SHC1;DVL2;E2F3;WNT9A
NF-kappa B signaling pathway	3/95	0.86007960317269	1.0	0	0	0.631578947368421	0.09519810454070905	CSNK2A1;CHUK;GADD45B
Amphetamine addiction	2/68	0.860502636162266	1.0	0	0	0.588235294117647	0.08837564694787858	TH;STX1A
Fc epsilon RI signaling pathway	2/68	0.860502636162266	1.0	0	0	0.588235294117647	0.08837564694787858	PLA2G4B;MAPK12
Glycolysis / Gluconeogenesis	2/68	0.860502636162266	1.0	0	0	0.588235294117647	0.08837564694787858	ADH1C;GAPDH
Adipocytokine signaling pathway	2/69	0.8659715129706728	1.0	0	0	0.5797101449275363	0.08342218313842696	PRKAA1;CHUK
Neuroactive ligand-receptor interaction	13/338	0.8684541992691425	1.0	0	0	0.7692307692307693	0.10849263856380123	EDN1;CHRNB3;CHRM4;HTR2C;HTR2A;ADRA2C;GIP;CHRNG;MTNR1B;MC5R;KISS1R;TSPO;F2RL3
Platelet activation	4/124	0.8730902649815165	1.0	0	0	0.6451612903225806	0.08755892398339275	MYLK2;PLA2G4B;MAPK12;F2RL3
Pancreatic secretion	3/98	0.8738518002871013	1.0	0	0	0.6122448979591836	0.08255784648566498	CELA2A;PLA2G2E;ATP2A2
Choline metabolism in cancer	3/99	0.8781684208695373	1.0	0	0	0.6060606060606061	0.07873750329026426	CHKA;PLA2G4B;EIF4EBP1
Progesterone-mediated oocyte maturation	3/99	0.8781684208695373	1.0	0	0	0.6060606060606061	0.07873750329026426	CCNA1;MAPK12;CDC25B
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	2/72	0.8812175551168138	1.0	0	0	0.5555555555555555	0.07025041245674381	TCF7L1;ATP2A2
AGE-RAGE signaling pathway in diabetic complications	3/100	0.8823533306415342	1.0	0	0	0.6	0.07509762093621879	STAT5A;EDN1;MAPK12
T cell receptor signaling pathway	3/101	0.8864097011888528	1.0	0	0	0.594059405940594	0.07162931796059352	CHUK;NCK2;MAPK12
Longevity regulating pathway	3/102	0.8903406760313634	1.0	0	0	0.588235294117647	0.06832418084741279	PRKAA1;ATG101;EIF4EBP1
Inositol phosphate metabolism	2/74	0.8904734986911036	1.0	0	0	0.5405405405405406	0.06270374958254536	SYNJ1;PLCH2
Cushing syndrome	5/155	0.892191742499279	1.0	0	0	0.6451612903225806	0.0735962655119009	TCF7L1;KMT2A;DVL2;E2F3;WNT9A
Hepatitis C	5/155	0.892191742499279	1.0	0	0	0.6451612903225806	0.0735962655119009	CLDN4;CHUK;PPP2R1A;CLDN9;E2F3
Chagas disease (American trypanosomiasis)	3/103	0.8941493670111881	1.0	0	0	0.5825242718446602	0.06517423722567385	CHUK;PPP2R1A;MAPK12
Rap1 signaling pathway	7/206	0.8949466944667533	1.0	0	0	0.6796116504854368	0.07543085943225253	CDH1;FGF19;FLT4;MAPK12;BCAR1;CRKL;F2RL3
C-type lectin receptor signaling pathway	3/104	0.8978388517991447	1.0	0	0	0.5769230769230769	0.0621719302632217	CHUK;CD209;MAPK12
Proteasome	1/45	0.9008174591944802	1.0	0	0	0.4444444444444444	0.046423395514619575	PSMD4
FoxO signaling pathway	4/132	0.901525280416235	1.0	0	0	0.6060606060606061	0.06282860249592064	PRKAA1;GADD45B;CHUK;MAPK12
Cellular senescence	5/160	0.9070372427064196	1.0	0	0	0.625	0.060982355182296055	CCNA1;GADD45B;EIF4EBP1;E2F3;MAPK12
Human immunodeficiency virus 1 infection	7/212	0.9102489016760925	1.0	0	0	0.660377358490566	0.06210003677512062	DDB1;APOBEC3G;CHUK;AP1S3;AP1M2;MAPK12;CRKL
Hedgehog signaling pathway	1/47	0.9105090567783704	1.0	0	0	0.42553191489361697	0.03989422673431822	SUFU
Sphingolipid metabolism	1/47	0.9105090567783704	1.0	0	0	0.42553191489361697	0.03989422673431822	GBA
Calcium signaling pathway	6/188	0.9131597476168598	1.0	0	0	0.6382978723404255	0.0579858151181627	MYLK2;STIM2;TNNC2;HTR2C;ATP2A2;HTR2A
Apelin signaling pathway	4/137	0.9162983017532836	1.0	0	0	0.583941605839416	0.05104426883901789	MYLK2;NOTCH3;PRKAA1;CDH1
Estrogen signaling pathway	4/137	0.9162983017532836	1.0	0	0	0.583941605839416	0.05104426883901789	NCOA1;KRT17;SHC1;KRT34
Chemokine signaling pathway	6/190	0.9179445909739374	1.0	0	0	0.631578947368421	0.054074683325986896	FGR;CHUK;SHC1;CCR8;BCAR1;CRKL
Malaria	1/49	0.919254474341766	1.0	0	0	0.4081632653061224	0.034364200583535946	CR1
Ovarian steroidogenesis	1/49	0.919254474341766	1.0	0	0	0.4081632653061224	0.034364200583535946	PLA2G4B
Protein processing in endoplasmic reticulum	5/165	0.9200650455836688	1.0	0	0	0.6060606060606061	0.05049146043449751	MBTPS1;GANAB;PRKCSH;RAD23A;DNAJC5G
Fluid shear stress and atherosclerosis	4/139	0.9216307962341534	1.0	0	0	0.5755395683453237	0.04697011427115409	EDN1;PRKAA1;CHUK;MAPK12
Vibrio cholerae infection	1/50	0.9233015685863551	1.0	0	0	0.39999999999999997	0.03191974852547144	ATP6V0D1
Peroxisome	2/83	0.9243958207118659	1.0	0	0	0.4819277108433735	0.03788670924051055	HMGCL;EHHADH
Taste transduction	2/83	0.9243958207118659	1.0	0	0	0.4819277108433735	0.03788670924051055	TAS2R10;TRPM5
Serotonergic synapse	3/113	0.9261680268010687	1.0	0	0	0.5309734513274336	0.04072545470868394	PLA2G4B;HTR2C;HTR2A
Amyotrophic lateral sclerosis (ALS)	1/51	0.9271460027962314	1.0	0	0	0.39215686274509803	0.029664402156312095	MAPK12
Mineral absorption	1/51	0.9271460027962314	1.0	0	0	0.39215686274509803	0.029664402156312095	MT1F
Apoptosis	4/143	0.931389987367667	1.0	0	0	0.5594405594405594	0.039763467737085244	TUBA1A;GADD45B;CHUK;BBC3
Insulin secretion	2/86	0.9333063042418757	1.0	0	0	0.46511627906976744	0.032103177510297835	STX1A;GIP
Salmonella infection	2/86	0.9333063042418757	1.0	0	0	0.46511627906976744	0.032103177510297835	PLEKHM2;MAPK12
Focal adhesion	6/199	0.9367347778999319	1.0	0	0	0.6030150753768844	0.03941010533489616	MYLK2;SHC1;LAMB2;FLT4;BCAR1;CRKL
Legionellosis	1/55	0.9406924613791231	1.0	0	0	0.3636363636363636	0.022232368682920493	CR1
GABAergic synapse	2/89	0.9412159961600209	1.0	0	0	0.449438202247191	0.02722814686661418	SLC6A13;SLC6A11
PI3K-Akt signaling pathway	12/354	0.9435045606829832	1.0	0	0	0.6779661016949152	0.03942649518167449	NTF4;PRKAA1;CHUK;PPP2R1A;EPO;BDNF;LAMB2;FGF19;FLT4;EIF4EBP1;MLST8;OSMR
TGF-beta signaling pathway	2/90	0.9436483877912323	1.0	0	0	0.4444444444444444	0.025778512347182387	TFDP1;PPP2R1A
Fc gamma R-mediated phagocytosis	2/91	0.9459848142593618	1.0	0	0	0.43956043956043955	0.024408247313871943	PLA2G4B;CRKL
GnRH signaling pathway	2/93	0.9503836736321627	1.0	0	0	0.43010752688172044	0.021887960833825593	PLA2G4B;MAPK12
Circadian entrainment	2/97	0.9581767039032599	1.0	0	0	0.41237113402061853	0.017617759662583495	PER1;MTNR1B
Purine metabolism	3/129	0.9594354431483884	1.0	0	0	0.46511627906976744	0.01926058026089093	NT5C3B;RRM1;NPR2
Regulation of actin cytoskeleton	6/214	0.9596811351161484	1.0	0	0	0.5607476635514018	0.023077121840337618	MYLK2;CHRM4;FGF19;INSRR;BCAR1;CRKL
Relaxin signaling pathway	3/130	0.9609575692842738	1.0	0	0	0.46153846153846156	0.018380780149132046	EDN1;SHC1;MAPK12
Dopaminergic synapse	3/131	0.9624259105310855	1.0	0	0	0.4580152671755725	0.017541156574629197	TH;PPP2R1A;MAPK12
JAK-STAT signaling pathway	4/162	0.9643248581685346	1.0	0	0	0.49382716049382713	0.01793928461161327	STAT5A;EPO;OSMR;GFAP
Central carbon metabolism in cancer	1/65	0.9645452489317999	1.0	0	0	0.3076923076923077	0.011107241028940524	SIRT6
Glucagon signaling pathway	2/103	0.9677062755799263	1.0	0	0	0.38834951456310673	0.01274822216284486	PRKAA1;PPP4C
cGMP-PKG signaling pathway	4/166	0.9690459398300972	1.0	0	0	0.4819277108433735	0.01515337768182299	MYLK2;NPR2;ATP2A2;ADRA2C
Toll-like receptor signaling pathway	2/104	0.9690762134019278	1.0	0	0	0.38461538461538464	0.0120815456087189	CHUK;MAPK12
Renal cell carcinoma	1/69	0.9711417402987961	1.0	0	0	0.2898550724637681	0.00848778197469868	CRKL
Renin secretion	1/69	0.9711417402987961	1.0	0	0	0.2898550724637681	0.00848778197469868	EDN1
Human cytomegalovirus infection	6/225	0.9713829486551508	1.0	0	0	0.5333333333333333	0.01548506805110519	CHUK;EIF4EBP1;E2F3;MAPK12;BCAR1;CRKL
B cell receptor signaling pathway	1/71	0.9739647545480367	1.0	0	0	0.28169014084507044	0.00743103163098366	CHUK
Insulin resistance	2/108	0.9740164985643297	1.0	0	0	0.37037037037037035	0.009750754261227252	SREBF1;PRKAA1
Bile secretion	1/72	0.9752710378445755	1.0	0	0	0.27777777777777773	0.006955516411879717	ABCG8
PPAR signaling pathway	1/74	0.9776904281936729	1.0	0	0	0.2702702702702703	0.00609789044447976	EHHADH
Thyroid hormone synthesis	1/74	0.9776904281936729	1.0	0	0	0.2702702702702703	0.00609789044447976	TG
Cholinergic synapse	2/112	0.9781900395096983	1.0	0	0	0.3571428571428571	0.007875469070295836	ACHE;CHRM4
Adrenergic signaling in cardiomyocytes	3/145	0.9782218699760653	1.0	0	0	0.41379310344827586	0.009111216728335437	PPP2R1A;ATP2A2;MAPK12
Gastric acid secretion	1/75	0.9788099305759348	1.0	0	0	0.26666666666666666	0.005711413813620137	MYLK2
Pertussis	1/76	0.9798733026216075	1.0	0	0	0.2631578947368421	0.005350525977491548	MAPK12
Axon guidance	4/181	0.9820330194501505	1.0	0	0	0.4419889502762431	0.008013412816934464	FES;PLXNB3;NCK2;RHOD
Sphingolipid signaling pathway	2/119	0.9839830371412186	1.0	0	0	0.3361344537815126	0.005427435548267131	PPP2R1A;MAPK12
MicroRNAs in cancer	8/299	0.9841281952173011	1.0	0	0	0.5351170568561873	0.008561397042497167	NOTCH3;SHC1;CDCA5;NOTCH4;E2F3;MIR192;CRKL;CDC25B
Kaposi sarcoma-associated herpesvirus infection	4/186	0.9850692674529925	1.0	0	0	0.43010752688172044	0.0064702442990289336	CHUK;CCR8;E2F3;MAPK12
ECM-receptor interaction	1/82	0.9852227825319085	1.0	0	0	0.24390243902439024	0.003631094688901337	LAMB2
Herpes simplex virus 1 infection	15/492	0.9876632955714929	1.0	0	0	0.6097560975609756	0.007569166630307924	CHUK;ZNF705E;NXF1;HLA-DMA;HLA-DMB;ZNF83;EIF4EBP1;ZNF689;ZNF534;ZNF841;ZNF433;ZNF256;HLA-DQB1;ZNF222;ZNF200
Oocyte meiosis	2/125	0.9877333512529541	1.0	0	0	0.32	0.0039496016179910295	PPP2R1A;MAPK12
Salivary secretion	1/90	0.9902133488804308	1.0	0	0	0.2222222222222222	0.002185523367001884	MUC5B
Natural killer cell mediated cytotoxicity	2/131	0.9906225720039081	1.0	0	0	0.30534351145038163	0.002876846685028434	SHC1;ULBP3
Dilated cardiomyopathy (DCM)	1/91	0.9907047643496917	1.0	0	0	0.21978021978021978	0.002052462844095697	ATP2A2
Proteoglycans in cancer	4/201	0.991518731265461	1.0	0	0	0.3980099502487562	0.0033900256137638944	DDX5;NANOG;WNT9A;MAPK12
Amoebiasis	1/96	0.9928157700996559	1.0	0	0	0.20833333333333331	0.0015021168229316978	LAMB2
Ubiquitin mediated proteolysis	2/137	0.9928432555950474	1.0	0	0	0.291970802919708	0.002097073502741547	DDB1;UBE2L6
Phosphatidylinositol signaling system	1/99	0.9938447802854349	1.0	0	0	0.20202020202020202	0.0012473214492474535	SYNJ1
NOD-like receptor signaling pathway	3/178	0.9942948580485411	1.0	0	0	0.33707865168539325	0.0019285882375560499	CHUK;NOD2;MAPK12
cAMP signaling pathway	4/212	0.9944476368655043	1.0	0	0	0.3773584905660377	0.002101069735393908	EDN1;BDNF;ATP2A2;GIP
Phospholipase D signaling pathway	2/148	0.9956565181732089	1.0	0	0	0.2702702702702703	0.0011764708507407508	SHC1;PLA2G4B
Parathyroid hormone synthesis, secretion and action	1/106	0.9957088736018097	1.0	0	0	0.18867924528301885	8.113886235340445E-4	NACA
Glutamatergic synapse	1/114	0.9971588332597501	1.0	0	0	0.17543859649122806	4.991597395875789E-4	PLA2G4B
Spliceosome	1/134	0.99898625000142	1.0	0	0	0.14925373134328357	1.5138271502198073E-4	DDX5
Olfactory transduction	9/444	0.999641181780525	1.0	0	0	0.40540540540540543	1.454929500550681E-4	OR2C3;OR8B12;OR10H3;OR6C74;OR1F1;OR10G3;OR2K2;OR7D2;OR6T1
Cytokine-cytokine receptor interaction	4/294	0.9998003454606037	1.0	0	0	0.27210884353741494	5.433318993663105E-5	EPO;CCR8;TNFRSF25;OSMR
